(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

EMPOWERING PATIENTS TO CONQUER CANCER

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

EMPOWERING PATIENTS TO CONQUER CANCER

ST13

US500000090597877

Class

36

Filing

90597877

Registration

6704342

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

17

Latest update

08/24/2023

Trademark type

Word

Nice classes

36

Filing date

03/23/2021

Registration date

04/19/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/19/2022

Last transaction

08/24/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

11/17/2020

First use in commerce

11/17/2020

Drawing code

4

Owner type

03

Owner location

Provo, UT

Examiner

BLANE, SUZANNE

Law office

M50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Thunder Biotech, Inc.

Representatives

TERRENCE J. EDWARDS TECHLAW VENTURES, PLLC

Technical classification

Nice Classes

Class 36

Vienna Codes

No Vienna codes available.

Goods and services

Class 36

Charitable fundraising services; Charitable fundraising to support and raise awareness of immunotherapy treatmentscancer researchhelping to pay for cancer treatments for children and adults

Publications

History of USPTO decisions and trademark events.

17 publications found

R.PR

REGISTERED-PRINCIPAL REGISTER

04/19/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/01/2022

PUBO

PUBLISHED FOR OPPOSITION

02/01/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/12/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/30/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

12/30/2021

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

12/30/2021

GNEA

EXAMINERS AMENDMENT E-MAILED

12/30/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

12/30/2021

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

12/16/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/16/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/05/2021

GNRT

NON-FINAL ACTION E-MAILED

11/05/2021

CNRT

NON-FINAL ACTION WRITTEN

11/05/2021

DOCK

ASSIGNED TO EXAMINER

10/27/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/28/2021

NWAP

NEW APPLICATION ENTERED

03/26/2021

Continuous trademark protection

Get notified about every new filing that threatens EMPOWERING PATIENTS TO CONQUER CANCER or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.